Cell Therapeutics Inc (NASDAQ:CTIC)
CAPS Rating:
The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.
RSS Headlines
Fool UK
Recs
Obvious example of stock market manipulation. CTIC is worthless.
Good call :)